PARP抑制剂治疗brca缺陷上皮性卵巢癌的研究进展

{"title":"PARP抑制剂治疗brca缺陷上皮性卵巢癌的研究进展","authors":"E. Parkes, N. Mccabe, R. Kennedy","doi":"10.1016/B978-0-12-811785-9.00036-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":88783,"journal":{"name":"Translational oncogenomics","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of PARP Inhibitors for BRCA-Deficient Epithelial Ovarian Cancer\",\"authors\":\"E. Parkes, N. Mccabe, R. Kennedy\",\"doi\":\"10.1016/B978-0-12-811785-9.00036-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":88783,\"journal\":{\"name\":\"Translational oncogenomics\",\"volume\":\"25 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-11-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational oncogenomics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/B978-0-12-811785-9.00036-3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational oncogenomics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/B978-0-12-811785-9.00036-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}